Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 12, 2003

View Archived Issues

Use of rhBMP-2 in lumbar arthrodesis

Four series of tyrosine kinase inhibitors identified at Ariad

Novel antibacterial DNA polymerase III inhibitors prepared and tested at Bayer

New antibacterial agents with PPAT-inhibitory activity discovered at Bayer

Bayer identifies novel thyroid hormone-like agents with utility in arteriosclerosis

Pfizer claims MTP/apo B secretion inhibitors for use in obesity and related disorders

Elan and Pharmacia team identifies novel beta-secretase inhibitors

OSI to acquire Cell Pathways

MedImmune responds to FluMist complete response letter

Pharmacopeia and AstraZeneca extend research collaboration

Milestone achieved in Pharmacopeia and Berlex collaboration

Johnson & Johnson to acquire Scios

Milnacipran improves pain in phase II FMS study

BioMarin presents overview of recent highlights

Transgene announces encouraging results from phase I oncology trials

Preclinical profile of HIV-specific CCR5 inhibitor presented in Boston

Favorable anti-HIV interactions for combination of CCR5 inhibitor and other antiretrovirals

Excellent activity reported for TMC-114 against protease inhibitor-resistant HIV

Anti-HIV effects of Racivir + d4T + efavirenz sustained after cessation of treatment in humans

AstraZeneca completes MRP in E.U. for Symbicort Turbuhaler in COPD

FDA approves Zoloft for social anxiety disorder

AstraZeneca submits MAA for Iressa for advanced NSCLC

SuperGen submits second module of rolling NDA for Orathecin

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...